Table 2 Changes in clinical parameters and body composition.
Parameter | Pre-implant (Baseline) | Follow-up (3-Month) | Follow-up (6-month) |
|---|---|---|---|
n = 300 | n = 273 | n = 200 | |
FEV1, L | 0.75 (0.3–1.6) | 0.85 (0.38–1.9)*** | 0.81 (0.32–1.65)*** |
RV, L | 5.7 (3.2–11.6) | 4.9 (2.9–12.3)*** | 4.9 (3.0–9.5)*** |
IVC, L | 2.2 (0.6–4.6) | 2.56 (1.1–4.9)*** | 2.5 (0.86–4.9)*** |
6MWD, m | 280 (95–520) | 320 (110–545)*** | 310 (90–600)*** |
CAT score | 27 (14–38) | 24 (15–35)*** | 25 (12–37)*** |
Muscle, BAR | 1.632 (0.9–2.7) | 1.638 (1–3) | 1.635 (0.77–3.2) |
Δ, % | – | 0.37 | 0.18 |
TAT, BAR | 2.86 (0.25–10.3) | 3.01 (0.34–14.7)* | 3.00 (0.31–9)* |
Δ, % | – | 5.2 | 4.9 |
SAT, BAR | 1.95 (0.08–7.9) | 1.94 (0.1–6.1) | 1.88 (0.09–6.4) |
Δ, % | – | –0.51 | –3.59 |
PAT, BAR | 0.16 (0.03–0.58) | 0.17 (0.04–0.53) | 0.17 (0.04–0.5)* |
Δ, % | – | 6.3 | 6.3 |
IMAT, BAR | 0.54 (0.09–1.87) | 0.58 (0.1–2.74) | 0.57 (0.12–1.44) |
Δ, % | – | 7.4 | 5.5 |
EAT, BAR | 0.08 (0.01–0.28) | 0.08 (0.02–0.3) | 0.08 (0.02–0.28) |
Δ, % | – | 0 | 0 |
